BiomX invests $50K and issues 1.3M shares to secure exclusive drone testing solution rights from Motomea.
BiomX (PHGE) has acquired a 10% equity stake in Motomea, gaining exclusive rights to develop and distribute drone testing solutions. The deal includes a $50K cash payment and the issuance of 1.3 million restricted shares, pending final terms.
The move follows BiomX’s strategic push to diversify its technology portfolio beyond its core microbiome platform. No prior financial details or consensus estimates were disclosed for this transaction.
Shares of BiomX remained unchanged in pre-market trading, reflecting limited immediate market reaction to the announcement.